MX9303557A - Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel. - Google Patents

Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.

Info

Publication number
MX9303557A
MX9303557A MX9303557A MX9303557A MX9303557A MX 9303557 A MX9303557 A MX 9303557A MX 9303557 A MX9303557 A MX 9303557A MX 9303557 A MX9303557 A MX 9303557A MX 9303557 A MX9303557 A MX 9303557A
Authority
MX
Mexico
Prior art keywords
skin
spironolactone
androgen
administration
lauramide
Prior art date
Application number
MX9303557A
Other languages
English (en)
Inventor
Francisco Jose Evarist Stefano
Dario Norberto Ramon Carrara
Original Assignee
Beta Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beta Pharm Co filed Critical Beta Pharm Co
Publication of MX9303557A publication Critical patent/MX9303557A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Esta invención se refiere a un método para al administración de un antiandrógeno sistemáticamente activo, en particular la espironolactona, a través de al piel. La invención revela una formulación farmacéutica con buenas propiedades cosméticas y bajo potencial de irritación,. que resulta útil para el tratamiento tópico del acné vulgaris, la dermatitis seborreica y el hirsutismo.
MX9303557A 1992-08-06 1993-06-15 Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel. MX9303557A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92656192A 1992-08-06 1992-08-06

Publications (1)

Publication Number Publication Date
MX9303557A true MX9303557A (es) 1994-03-31

Family

ID=25453377

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9303557A MX9303557A (es) 1992-08-06 1993-06-15 Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.

Country Status (6)

Country Link
EP (1) EP0582458B1 (es)
AT (1) ATE130515T1 (es)
DE (1) DE69300854T2 (es)
DK (1) DK0582458T3 (es)
ES (1) ES2083254T3 (es)
MX (1) MX9303557A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
US5693330A (en) * 1996-04-25 1997-12-02 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing melinamide and a retinoid
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
US5955092A (en) * 1996-09-27 1999-09-21 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
US5747051A (en) * 1996-09-27 1998-05-05 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
DE19843784A1 (de) * 1998-09-24 2000-04-20 Temic Semiconductor Gmbh Schaltungsanordnung zur Leistungsverstärkung
AU5460800A (en) * 1999-06-02 2000-12-18 Aviana Biopharm Pharmaceutical transdermal compositions
US9241944B2 (en) * 2010-06-16 2016-01-26 Institut National De La Santé Et De La Recherche Médicale (Inserm) Methods and compositions for stimulating reepithelialisation during wound healing
ES2984281T3 (es) 2015-03-03 2024-10-29 Richard W Yee Composiciones que comprenden un antagonista de la aldosterona para su uso en el tratamiento de ojos secos
US11524016B2 (en) 2020-07-17 2022-12-13 Amy Thorne Compositions and methods for the topical administration of spironolactone for the treatment of cutaneous signs of excess androgen and chronic stress response

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI59534C (fi) * 1979-10-31 1981-09-10 Orion Yhtymae Oy Vaordmedel foer fraemjande av haorvaext och hindrande av mjaell
US4347245A (en) * 1981-05-26 1982-08-31 German Shapiro Spironolactone-containing composition and use thereof
IT1194185B (it) * 1983-04-01 1988-09-14 Schiapparelli Farma Composizione per il trattamento dell'acne
FR2588755B3 (fr) * 1985-10-21 1988-01-22 Aron Brunetiere Robert Composition therapeutique a base de spironolactone destinee au traitement des alopecies androgenogenetiques
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
EP0410348A1 (en) * 1989-07-26 1991-01-30 G.D. Searle & Co. Topical spironolactone composition
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices

Also Published As

Publication number Publication date
DE69300854T2 (de) 1996-06-05
DK0582458T3 (da) 1996-04-09
ES2083254T3 (es) 1996-04-01
EP0582458B1 (en) 1995-11-22
ATE130515T1 (de) 1995-12-15
DE69300854D1 (de) 1996-01-04
EP0582458A1 (en) 1994-02-09

Similar Documents

Publication Publication Date Title
TW221027B (es)
ES2174953T3 (es) Composiciones dermatologicas que contienen peroxido de benzoilo y un compuesto que reduce la irritacion de la piel.
ZA931983B (en) Agent for regulating the greasiness of the skin
PH22509A (en) Dentifrice composition
BR9914925A (pt) Processos para reduzir o crescimento de cabelo de mamìfero, para tratar uma área de pele, e, para produzir uma composição para inibir crescimento do cabelo de mamìfero, uso de um inibidor de fosfatase alcalina, e, composição usada para inibir crescimento de cabelo de mamìfero.
MX9303557A (es) Metodo para la administracion de un antiandrogeno, en particular, espironolactona, a traves de la piel.
MX9703693A (es) Tratamiento profilactico de dermatitis alergica por contacto.
BR9407824A (pt) Processos para tratar e para interromper e reverter alopécia androgência e para diminuir o nível de 5 &-di-hidro-testosterona no escalpo humano
MX9704775A (es) Formulaciones reductoras de irritacion de la piel y su uso.
FR2687913B1 (es)
ATE172871T1 (de) Lokal anwendbares präparat zur hemmung des haarwuchses
AU571003B2 (en) Scalp treatment by lipase application
IE831548L (en) Anti-sebum hydrocarbon
EP0678013A1 (en) COMPOSITION FOR HAIR CARE.
ZA935086B (en) Skin regenerating cosmetic composition
MX9302419A (es) Derivados de acido tetronico, tiotetronico y tetramico.
EP0204586A3 (en) Stabilizer for hair compositions and such compositions
EP0451869A3 (en) Use of steroid derivatives in the treatment of endometriosis
AU619608B2 (en) 3beta,17beta-hydroxy-substituted steroids and related steroidal compounds
ES8706027A1 (es) Procedimiento de obtencion de una composicion para el tratamiento de vitiligo
EP0346490A4 (en) Hair growth promoting agent
EP0257928A3 (en) Suntanning composition
IT1242042B (it) Composizione a base di estratti vegetali rigenerante delle cellule.

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees